Professional Documents
Culture Documents
ALBA LÚCIA
LUCIA BOTURA LEITE DE BARROS P h D , R N
Associate Professor, Nursing Department and Director of Nursing, Hospital Sa˜o Paulo, Federal
University of Sa˜o Paulo, Sa˜o Paulo City, Brazil
SOLANGE DICCINI P h D, RN
Adjoint Professor, Nursing Department, Federal University of Sa˜o Paulo, Sa˜o Paulo City, Brazil
Summary
• The objective of this study was to verify the incidence of nosocomial
pneumonia in intubated and extended mechanically ventilated patients having
endotracheal suctioning by an open vs. closed suction method aiming to decrease
nosocomial pneumonia.
• Twenty-four (51.1%) patients received open-tracheal suction and 23 (48.9%)
received closed-tracheal suction. The inclusion criteria were: surgical and
medical patients older than 13 years, undergoing mechanical ventilation for more
than 48 hours. Additional data were gathered using the Acute Physiology and
Chronic Health Evaluation II, and details on smoking, alcoholism, diabetes
mellitus, renal failure, previous lung disease, and previous use of antibiotics,
steroids, H2 antagonists and antacids.
• Among the 24 patients having open-tracheal suction, 11 developed nosocomial
pneumonia while of the 23 patients undergoing closed-tracheal suction, seven
developed infection (P ¼ 0.278). Risk factors for nosocomial pneumonia were
not significantly different between the two groups. In the final logistical
regression model the following variables remained: groups (open and closed)
[odds ratio (OR) ¼ 0.014; confidence interval (CI) ¼ 0.001–0.416; P ¼ 0.014]
and use of prior antibiotics (OR ¼ 2.297; CI ¼ 1.244–4.242; P ¼ 0.008).
• Use of a closed suction system did not decrease the incidence of nosocomial
pneumonia when compared with the open system. The exogenous risk factors
were the most important for acquiring this infection.
endotracheal suction, and those intubated on odd dates Among the 24 patients having open suction, 11 (45.8%)
had closed suction. developed VAP, while of the 23 having closed suction,
Additional data gathered were Acute Physiology and seven (30.4%) developed VAP (P ¼ 0.278).
Chronic Health Evaluation (APACHE) II scores to verify No statistically significant differences were found
differences in illness severity; risk factors for the devel- between the two groups for smoking (P ¼ 0.450), alco-
opment of VAP such as smoking, alcoholism, previous holism (P ¼ 0.489), previous lung disease (P ¼ 1.000),
lung disease, diabetes mellitus, renal failure, and time of diabetes mellitus (P ¼ 0.724) and renal failure
use of antibiotics, H2 antagonist, antacids and steroids (P ¼ 1.000) (Table 1).
prior to the development of VAP. The APACHE II is a When these risk factors were compared with the
prognostic scoring system that can be used to predict the development of VAP in both groups, there were no
risk of death for multidiagnostic ICU patient groups. It statistically significance different (Tables 2 and 3).
consists of a numeric score (ranging from 0 to 71) derived Interesting results were obtained when the data on use
from three components: (1) points for extent of abnor- of steroids, antibiotics and H2 antagonist were analysed.
mality of 12 physiological parameters, (2) points for Although the ‘open’ group had used antibiotics and H2
increasing age, and (3) points for chronic health abnor- antagonists for less time, this use was significant for the
malities. The APACHE II scoring uses the worst values development of VAP. However, in the ‘closed’ group, the
for the initial ICU day. An increasing score reflects an
increased severity of disease and a higher risk of death in Table 1 Prevalence of risk factors for the development of ventilator
hospital (Seneff et al., 1995). associated pneumonia (VAP) with the use of open and closed
endotracheal suction systems
Results
Table 3 Prevalence of risk factors for the development of ventilator
Forty-seven patients were randomized, with 24 (51.1%) associated pneumonia (VAP) in the closed suction group
receiving open suction and 23 (48.9%) closed suction.
There was no statistically significant difference VAP
(P ¼ 0.296) when subjects were grouped by cause (car-
Variable Yes (%) No (%) P-value
diac, neurological, pulmonary, septic shock and other
causes). The APACHE II scores were not significantly Smoking 1 (14.3) 6 (37.5) 0.366
different between the two groups, and had a median of 24 Alcoholism 1 (14.3) – 0.304
for the ‘open’ group and 22 for the ‘closed’ group, showing Previous lung disease – 4 (25.0) 0.273
Diabetes mellitus 1 (14.3) 4 (25.0) 1.000
homogeneity between the groups in relation to the severity Renal failure – 1 (6.3) 1.000
of illness.
Table 4 Distribution of risk factors for the development of Table 6 Final logistical regression model of independent variables
ventilator associated pneumonia (VAP) in the open suction group chosen as risk factors for the development of ventilator associated
pneumonia
VAP
IC (95%)
Variable Yes No P-value Variable Odds ratio (inferior–superior) P-value
patients with elevated inspired oxygen fraction, nosoco- and P ¼ 0.046, respectively, only for patients receiving
mial pneumonia, elevation in intracranial pressure, atelec- open suction, although the length of use of these
tasis and haemodynamic instability (Ritz et al., 1986; medications was less in this group (Table 4).
Taggart et al., 1988; Deppe et al., 1990; Crosby & The use of H2 antagonists for the prevention of stress
Parsons, 1992; Johnson et al., 1994). ulcers in critically ill patients or those having mechanical
In agreement with Crimlisk et al. (1994) and Blackwood ventilation is considered controversial. Torres et al.
& Webb (1998), we emphasize the following positive (1990), studying the incidence, risk factors and prognosis
aspects of closed suction systems: guarantee of aseptic of VAP, found that this was twice as high in patients
chain in case of inadequate handwashing; catheter con- receiving antacids and/or H2 antagonists vs. those not
tamination by a non-sterile object; decrease of environ- receiving these (37% vs. 19%; P ¼ 0.007). However,
mental and staff contamination, because of avoiding circuit there was no reference to the suction method used.
condensate aerosol and/or tracheal secretion expelled The American Thoracic Society (1995) reports that in
during suctioning reaching the operator; readiness for three meta-analytic studies the use of sulcralfate, which
suction in patients with bronchial secretions because the did not elevate gastric pH, was associated with a reduced
equipment remains attached between endotracheal tube incidence of pneumonia, when compared with the use of a
and mechanical ventilator; maintenance of positive end H2 antagonist. However, the use of H2 antagonist alone
expiratory pressure, avoiding microatelectasis; and did not increase the risk of pneumonia when compared
removal of the need to hyperoxygenate patients before with placebo.
the procedure, unless oxygen desaturation be detected. These conflicting results with H2 antagonist reflect
Zeitoun et al. (2000) carried out a study with 59 the fact that this elevates gastric pH. Furthermore, in the
patients to evaluate the cost of equipment used in analyses described there was no consideration of the
open and closed suction systems and concluded that the impact of concurrent enteral feeding.
closed technique was showed cheaper (R$60.34) compared Fernandes et al. (2000a) state that use of sucralfate has
with the open method (R$69.73; where R stands for ‘Real’, been recommended by Hospital Infection Control Prac-
the currency of Brazil) (P ¼ 0.001). tices Advisory Committee (HICPAC). Fernandes et al.
With regard to the variables (smoking, alcoholism, (2000b) state that sucralfate has been showed to be a
previous pneumopathy, diabetes mellitus and renal failure) potential substitute for H2 antagonist and antacid, and has
analysed as risks factors for the development of VAP, and been recommended by the HICPAC until conclusive
that also define the epidemiological profile of each patient, evidence on its effect is produced.
there were no statistically significance differences when Chastre & Fagon (1994) describe how, in a prospective
the prevalent of these variables in the groups were study of 52 cases of nosocomial pneumonia diagnosed in
calculated (Table 1). an ICU, the infection was directly influenced by the use of
When these same variables were compared with the antibiotics prior to its development, with a rate of 65% in
development of VAP in both groups, there were also no patients receiving antibiotic therapy against 19% in those
statistically significance different (Tables 2 and 3). not receiving this. These data coincide in part with our
Despite the harmful effects of smoking, it was not possible study, which showed, in logistic regression, that prior
to establish an association with VAP because of the small antibiotic use is harmful, increasing the chance of
number when the sample was stratified. For the study to acquiring VAP. However, why this chance increases when
have greater power (80–90%), it should be repeated as a the patient has open endotracheal suction is a question
multicentre study. that deserves more research.
Medeiros (1993) carried out a study of risks factors for
the development and mortality of nosocomial pneumonia
Conclusion
in adult ICUs and found that alcoholism, chronic
obstructive pulmonary disease and other variables acted In this study the use of a closed tracheal suction system
as risk factors. did not decrease or prevent the development of VAP
When the median value was calculated for the length of when compared with an open system. However, the
use (in days) of steroids, antibiotics and H2 antagonists study has two limitations. The first relates to the sample
prior to the development of VAP and analysed as a risk size: the absence of statistically significant differences for
factor for infection associated with the use of open risk factors may be because of the small numbers that
and closed endotracheal suction systems, it showed remained when the samples were stratified. The second
statistically significant differences P ¼ 0.043, P ¼ 0.002 limitation refers to the use of the clinical criteria for the
diagnosis of VAP, because of their questionable accu- George D.L. (1996) Nosocomial pneumonia. In Hospital Epidemi-
racy. We plan to extend our work through a multicentre ology and Infection Control (Mayhall C.G., ed.). Lippincott
Williams & Wilkins, Baltimore, pp. 175–195.
study and to use both clinical and microbiological
Grossi S.A.A. & Santos B.M.O. (1994) Prevenção da hipoxemia
criteria. durante a aspiração endotraqueal. Revista Latino-Americana de
Enfermagem 2(2), 87–101.
Hayner C.E. & Baughman R.P. (1995) Nosocomial pneumonia: a
References review of diagnostic approaches. Infection Medicine 12(7), 322–330.
American Thoracic Society (1995) Hospital-acquired pneumonia in Johnson K.L., Kearney P.A., Johnson S.B., Niblett J.B., MacMillan
adults: diagnosis, assessment of severity, initial antimicrobial N.L. & MacClain R.E. (1994) Closed versus open endotracheal
therapy, and preventative strategies. A consensus statement. suctioning: costs and physiologic consequences. Critical Care
American Journal of Respiratory Critical Care Medicine 513, 1711– Medicine 22(4), 658–666.
1725. Kollef H.M., Skubas N.J. & Sundt T.M. (1999) A randomized
Blackwood B. & Webb C.H. (1998) Closed tracheal suctioning clinical trial of continuous aspiration of subglottic secretions in
systems and infection control in intensive care unit. Journal of cardiac surgery patients. Chest 116(5), 1339–1345.
Hospital Infection 39, 315–321. Martino M.D.V. (1998) Infecções do trato respiratório inferior. In
Bonten M.J.M. & Bergmans D.C.J.J. (1999) Nosocomial pneumo- Manual de Microbiologia Clı´nica Aplicada Ao Controle de Infecça˜o
nia. In Hospital Epidemiology and Infection Control, 2nd edn Hospitalar. APECIH, São Paulo, pp. 3–10.
(Mayhall C.G., ed.). Lippincott Williams & Wilkins, Philadelphia, Medeiros E.A.S. (1993) Fatores de risco para aquisição e letalidade
pp. 211–238. de pneumonia hospitalar em adultos internados em unidade de
Brun-Buisson C., Sollet J.P., Schweich H., Brière S. & Petit C. terapia intensiva. Doctoral Thesis, Escola Paulista de Medicina,
(1998) Treatment of ventilator-associated pneumonia with Universidade Federal de São Paulo, São Paulo, p. 151.
Piperacillin-Tazobactam/Amikacin versus Ceftazidime/Amika- Meduri G.U. (1993) Diagnosis of ventilator associated pneumonia.
cin. A multicenter, randomized controlled trial. Clinical Infectious Infectious Disease Clinics of North America 7(2), 295–329.
Diseases 26, 346–354. Norman G.R. & Streine D.L. (1994) Biostatistics – the Bare
Chaster J. & Fargon J.Y. (1994) Invasive diagnostic test should be Essentials. Mosby Year Book, Inc., Canada.
routinely used to manage ventilated patients with suspect Rello J., Ricart M., Ausina V., Net A. & Prats G. (1992) Pneumonia
pneumonia. American Journal of Respiratory Critical Care due to haemophilus influenzae among mechanically ventilated
Medicine 150, 570–574. patients. Chest 102(5), 1562–1565.
Craven D.E., Steger K.A. & Laforce F.M. (1998) Pneumonia. In: Ritz R., Scott L.R., Coyle M.B. & Pierson D.J. (1986) Contamina-
Hospital Infections, 4th edn. Lippincott-Raven Publishers, tion of a multiple-use suction catheter in a closed-circuit system
Philadelphia, pp. 487–513. compared to contamination of a disposable, single-use suction
Crimlisk J.T., Paris R., McGonagle E.G., Calcutt J.A. & Farber catheter. Respiratory Care 31(11), 1086–1091.
H.W. (1994) The closed tracheal suction system: implications for Sampaio L.A.B.N. (1998) Processo ensino-aprendizagem da técnica
critical care nursing. Dimensions of Critical Care Nursing 13(6), de aspiração endotraqueal: avaliação da implantação de um
292–300. modelo padrão em um programa de educação continuada.
Crosby L.J. & Parsons L.C. (1992) Cerebrovascular response of Masters degree Dissertation, Escola de Enfermagem, Universi-
closed head-injured patients to a standardized endotracheal tube dade de São Paulo, São Paulo.
suctioning and manual hyperventilation procedure. Journal of Seneff M.G., Zimmerman J.E. & Knaus W.A. (1995) Severity of
Neuroscience Nursing 24(1), 40–49. illness indices and outcome prediction: development and evalu-
Deppe S.A., Kelly J.W., Thoi L.L., Chudy J.H., Longfield R.N., ation. In Textbook of Critical Care, 3rd edn (Shoemaker W.C.,
Ducey J.P., Truwit C.L. & Antopol M.R. (1990) Incidence of Ayres S.M., Grenvik A. & Holbrook P.R., eds). W.B. Saunders,
colonization, nosocomial pneumonia, and mortality in critically ill Philadelphia, pp. 1777–1786.
patients using a Trach care closed-suction system versus an open- Silva L.D. (1993) A infecção pulmonar no contexto da UTI: uma
suction system: prospective, randomized study. Critical Care contribuição para sua prevenção através do sistema de aspiração
Medicine 18(12), 1039–1393. traqueal empregado pela enfermagem. Revista de Enfermagem da
Fernandes A.T., Ribeiro Filho N. & Barroso E.A.R. (2000a) Universidade Estadual do Rio de Janeiro 1(2), 24–30.
Conceito, cadeia epidemiológica das infecções hospitalares e Taggart J.A., Dorinsky N.L. & Sheahan J.S. (1988) Airway
avaliação custo-benefı́cio das medidas de controle. In Infecça˜o pressures during closed system suctioning. Heart and Lung
Hospitalar E Suas Interfaces Na A´rea Da Sau´de (Fernandes A.T., 17(5), 536–542.
ed.). Atheneu, São Paulo, pp. 215–265. Torres A., Aznar R., Gatell J.M., Jiménez P., González J., Ferrer
Fernandes A.T., Zamorano P.O. & Torezan Filho M.A. (2000b) A., Celis R. & Roisin R.R. (1990) Incidence, risk and prognosis
Pneumonia hospitalar. In Infecça˜o Hospitalar E Suas Interfaces Na factors of nosocomial pneumonia in mechanically ventilated
A´rea Da Sau´de (Fernandes A.T., ed.). Atheneu, São Paulo, patients. American Review of Respiratory Disease 142, 523–528.
pp. 516–555. Zeitoun S.S., Gonçalves S.R., Barros A.L.B.L. & Diccini S. (2000)
Gaynes R.P. & Horan T.C. (1996) Surveillance of nosocomial Sistema aberto de aspiração endotraqueal versus sistema fechado
infections. In Hospital Epidemiology and Infection Control de aspiração endotraqueal: relação custo/benefı́cio e implicações
(Mayhall C.G., ed.). Lippincott Williams & Wilkins, Baltimore, para a assistência de enfermagem. Acta Paulista de Enfermagem 13,
pp. 1017–1103. 230–233.